Stimulation of type I collagen transcription in human skin fibroblasts by TGF-β: Involvement of Smad 3

Journal of Investigative Dermatology

Volumn 112, Issue 1, 1999, Pages 49-57

  Chen, Shu Jen ^a   Yuan, Weihua ^a   Mori, Yasuji ^a   Levenson, Anait ^a   Trojanowska, Maria ^a,b   Varga, John ^a,c  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Smad signaling

Indexed keywords

COLLAGEN TYPE 1; DNA; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROCOLLAGEN; SMAD3 PROTEIN; SMAD7 PROTEIN; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; DNA PROTEIN COMPLEX; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SKIN FIBROBLAST; TRANSCRIPTION REGULATION;

EID: 0032921867     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.1999.00477.x     Document Type: Article

References (49)

1. Andrews NC, Faller DV: A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 19:2499, 1991
2. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye-binding. Anal Biochem 72:248-254, 1976
3. Bruzdzinski CJ, Johnson MR, Goble CA, Winograd SS, Gelchrter TD: Mechanism of glucocorticoid induction of the rat plasminogen activator inhibitor-I gene in HTC rat hepatoma cells: identification of cis-acting regulatory elements. Mol Endocrinol 7:1169-1177, 1993
4. Chen Y, Lebrun JJ, Vale W: Regulation of transforming growth factor β- and activin-induced transcription by mammalian Mad proteins. Proc Natl Acad Sci USA 93:12992-12997, 1996
5. Chen Y, Bhushan A, Vale W: SMAD 8 mediates the signaling of the receptor serine kinase. Proc Natl Acad USA 94:12938-12943, 1997a
6. Chen X, Weisberg E, Fridmacher V, Watanabe M, Naco G, Whitman M: Smad 4 and FAST-1 in the assembly of activin-responsive factor. Nature 389:85-89, 1997b
7. Chung K-Y, Agarwal A, Uitto J, Mauviel A: An AP-1 binding sequence is essential for regulation of the human α1 (I) collagen (COLIA2) promoter activity by transforming growth factor-β. J Biol Chem 271:3272-3278, 1996
8. Dennler S, Itoh S, Vivien D, ten Dijke P, Huet S, Gauthier J-M: Direct binding of Smad3 and Smad4 to critical TGFβ-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J 17:3091-3100, 1998
9. Eppert K, Scherer SW, Ozcelik H, et al: MADR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell 86:543-552, 1996
10. Graff JM, Bansal A, Melton DA: Xenopus Mad proteins transduce distinct subsets of signals for the TGFβ superfamily. Cell. 85:479-487, 1996
11. Hahn SA, Schutte M, Shamsul Hoque ATM, et al: DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271:350-353, 1996
12. Hata A, Lagna G, Massague J, Hemmati-Brinalou A: Smad 6 inhibits BMP/Smad 1 signaling by specifically competing with the Smad 4 tumor suppressor. Genes Devt 12:186-197, 1998
13. Hayashi H, Abdollah S, Qiu Y, et al: The MAD-related protein Smad7 associates with tire TGFβ receptor and functions as an antagonist of TGFβ signaling. Cell 89:1165-1173, 1997
14. Hoodless PA, Haerry S, Abdollah M, Stapleton M, O'Connor MB, Attisano L, Wrana JL: MADR 1, a MAD-related protein that functions in BMP2 signaling pathways. Cell 85:489-500, 1996
15. Hu PP, Datto MB, Wang X-F: Molecular mechanisms of transforming growth factor-β signaling. Endocrinol Rev 19:349-363, 1998
16. Ihn H, LeRoy EC, Trojanowska M: Oncostatin M stimulates transcription of the human α2 (I) collagene gene via the Sp1/Sp3-binding site. J Biol Chem 272:24666-24672, 1997
17. Imamura T, Takase M, Nishihara A, Ocda E, Hanai J-I, Kawabata M, Miyazano K: Smad 6 inhihits signaling by the TGF-β superfamily. Nature 389:622-625, 1997
18. Inagaki Y, Truter S, Ramirez F: Transforming growth factor-β stimulates α2 (I) collagen gene expression through a cis-acting element that contains an Sp I-binding site. J Biol Chem 269:14828-14834, 1994
19. Ishisaki A, Yamato K, Nakao A, et al: Smad 7 is an activin-inducible inhibitor of activin-induced growth arrest and apoptosis in mouse B cells. J Biol Chem 273:24293-24296, 1998
20. Jimenez SA, Varga J, Olsen A, Li L, Diaz A, Herhal J, Koch J: Functional analysis of human α1 (I) procollagen gene promoter: differential activity in collagen-producing and nonproducing cells and response to transforming growth factor-β1. J Biol Chem 269:12684-12691, 1994
21. Kawakami T, Ihn H, Xu W, Smith E, LeRoy C, Trojanowska M: Increased expression of TGF-β receptors by seleroderma fibroblasts: evidence for contribution of autocrine TGF-β signaling to seleroderma phenotype. J Invest Dermatol 110:47-51, 1998
22. Keeton MR, Curriden SA, van Zonneveld AJ, Loskutoff DJ: Identification of regulatory sequences in the type 1 plasminogen activator inhibitor gene responsive to transforming growth factor β. J Biol Chem 266:23048-23052, 1991
23. Kim J, Johnson K, Chen HJ, Carroll S, Laughton A: Drosophila Mad binds to DNA and directly mediates activation of vestigial by Decapentaplegic. Nature 388:304-308, 1997
24. Labbe E, Silvestri C, Hoodless PA, Wrana JA, Attisano L: Smad2 and Smad3 positively and negatively regulate TGFβ-dependent transcription through the forkhead DNA-binding protein FAST2. Mol Cell 2:109-120, 1998
25. Lagna G, Hata A, Hemmati-Brivanou A, Massagué J: Partnership between DPC4 and SMAD proteins in TGF-β signaling pathways. Nature: 383:832-836, 1996
26. Liu F, Hata A, Baker JC, Doody J, Cárcamo J, Harland RM, Massagué J: A human Mad protein acting as a BMP-regulated transcriptional activator. Nature 381:620-623, 1996
27. Liu X, Sun Y, Constantinescu SN, Karam E, Weinberg RA, Lodish HF: Transforming growth factor β-induced phosphorylation of Smad 3 is required for growth inhibition and transcriptional induction in epithelial cells. Proc Natl Acad Sci USA 94:10669-10674, 1997
28. Macias-Silva M, Abdollah S, Hoodless PA, Pirone R, Attisano L, Wrana JL: MADR2 is a substrate of the TGFβ receptor and its phosphorylation is required for nuclear accumulation and signaling. Cell 87:1215-1224, 1996
29. Massagué J: TGFβ signaling: receptors, transducers, and Mad proteins. Cell 85:947-950, 1996
30. Moustakas A, Kardassis D: Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members. Proc Natl Acad Sci USA 95:6733-6738, 1998
31. Mucsi I, Goldberg HJ: Dominant-negative SMAD-3 interferes with transcriptional activation by multiple agonists. Biochem Biophys Res Commun 232:517-521, 1997
32. Nakao A, Afrakhte M, Morén A, et al: Identification of Smad 7, a TGF-β-inducible antagonist of TGF-β signaling. Nature 389:631-634, 1997a
33. Nakao A, Imamura T, Souchelnytskyi S, et al: TGF-β receptor-mediated signaling through Smad 2, Smad 3, and Smad 4. EMBO J 16:5353-5362, 1997b
34. Penttinen RP, Kobayashi S, Bornstein P: Transforming growth factor β increases mRNA for matrix proteins both in the presence and in the absence of changes in mRNA stability. Proc Natl Acad Sci USA 85:1105-1108, 1988
35. Savage C, Das P, Finelli AL, Townsend SR, Sun C-Y, Baird SE, Padgett RW: Caenorhabditis elegans genes sma-2, sma-3, and sma-4 define a conserved family of transforming growth factor β pathway components. Proc Natl Acad Sci USA 93:790-794, 1996
36. Sekelsky JJ, Newfeld SJ, Raftery LA, Chratoff EH, Gelbart WM: Genetic characterization and cloning of mothers against dpp, a gene required for decapentaplegic function in Drosophila melanogaster. Genetics 139:1347-1358, 1995
37. Topper JN, Cai J, Qiu Y, et al: Vascular MADs: Two novel MAD-related genes selectively inducible by flow in human vascular endothelium. Proc Natl Acad Soc USA 94:9314-9319, 1997
38. Varga J, Jimenez SA: Modulation of collagen gene expression: its relation to fibrosis in systemic sclerosis and other disorders. Ann Intern Med 122:60-62, 1995
39. Varga J, Rosenbloom J, Jimenez SA: Transforming growth factor β (TGFβ) causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblasts. Biochem J 247:597-604, 1987
40. Watanabe TK, Suzuki M, Omori Y, et al: Cloning and characterization of a novel member of the human Mad gene family (MADH6). Genomics 42:446-451, 1997
41. de Winter JP, Roelen BA, ten Dijke P, et al: DPC4 (SMAD4) mediates TGF-β1-induced growth inhibition and transcriptional responses in breast tumor cells. Oncogene 14:1891-1899, 1997
42. Wu R-Y, Zhang Y, Feng X-H, Derynck R: Heteromeric and homomeric interactions correlate with signaling activity and functional cooperativity of Smad 3 and Smad 4/DPC4. Mol Cell Biol 17:2521-2528, 1997
43. Yamamoto N, Akiyama S, Katagiri T, Namiki M, Kurokawa T, Suda T: Smad1 and Smad 5 act downstream of intracellular signaling of BMP-2 that inhibits myogenic differentiation and induces osteoblast differentiation in C2C12 myoblasts. Biochem Biophys Res Commun 238:574-580, 1997
44. Yang X, Li C, Xu X, Deng C: The tumor suppressor SMAD4/DPC4 is essential for epiblast proliferation and mesoderm induction in mice. Proc Natl Acad Sci USA 95:3667-3672, 1998
45. Yingling JM, Das P, Savage C, Zhang M, Padgett RW, Wang XF: Mammalian dwarfins are phosphorylated in response to TGF-β and are implicated in control of cell growth. Proc Natl Acad Sci USA 93:8940-8944, 1996
46. Yingling JM, Datto MB, Wong C, Frederick JP, Liberati NT, Wang XF: Tumor suppressor Smad 4 is a transforming growth factor β-inducible DNA binding protein. Mol Cell Biol 17:7019-7028, 1997
47. Zawel L, Dai JL, Buckhaults P, Zhou S, Kinzler KW, Vogelstein B, Kern SE: Human Smad 3 and Smad 4 are sequence-specific transcription activators. Mol Cell 1:611-617, 1998
48. Zhang Y, Feng X-H, Wu R-Y, Derynck R: Receptor-associated Mad homologues synergize as effectors of the TGF-β response. Nature 383:168-171, 1996
49. Zhou S, Buckhaults P, Zawel L, et al: Targeted deletion of Smad 4 shows it is required for TGF-β and activin signaling in colorectal cancer cells. Proc Natl Acad Sci USA 95:2412-2416, 1998